| Targeting Mcl-1 for the therapy of cancer BA Quinn, R Dash, B Azab, S Sarkar, SK Das, S Kumar, RA Oyesanya, ... Expert opinion on investigational drugs 20 (10), 1397-1411, 2011 | 249 | 2011 |
| Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water SM Mandal, S Dey, M Mandal, S Sarkar, S Maria-Neto, OL Franco Peptides 30 (4), 633-637, 2009 | 173 | 2009 |
| Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer S Rajput, BNP Kumar, S Sarkar, S Das, B Azab, PK Santhekadur, SK Das, ... PLoS One 8 (4), e61342, 2013 | 138 | 2013 |
| ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells S Sarkar, A Mazumdar, R Dash, D Sarkar, PB Fisher, M Mandal Cancer biology & therapy 9 (8), 592-603, 2010 | 109 | 2010 |
| Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression N Puvvada, S Rajput, BNP Kumar, S Sarkar, S Konar, KR Brunt, RR Rao, ... Scientific reports 5, 11760, 2015 | 89 | 2015 |
| Enzyme/Prodrug Systems for Cancer Gene Therapy OM Malekshah, X Chen, A Nomani, S Sarkar, A Hatefi Current pharmacology reports 2 (6), 299-308, 2016 | 84 | 2016 |
| Crosslinking of gelatin-based drug carriers by genipin induces changes in drug kinetic profiles in vitro G Thakur, A Mitra, D Rousseau, A Basak, S Sarkar, K Pal Journal of Materials Science: Materials in Medicine 22 (1), 115-123, 2011 | 83 | 2011 |
| Overcoming Akt induced therapeutic resistance in breast cancer through siRNA and thymoquinone encapsulated multilamellar gold niosomes S Rajput, N Puvvada, BNP Kumar, S Sarkar, S Konar, R Bharti, G Dey, ... Molecular pharmaceutics 12 (12), 4214-4225, 2015 | 76 | 2015 |
| Structural identification and cytotoxic activity of a polysaccharide from the fruits of Lagenaria siceraria (Lau) K Ghosh, K Chandra, AK Ojha, S Sarkar, SS Islam Carbohydrate research 344 (5), 693-698, 2009 | 71 | 2009 |
| Biomarkers for the diagnosis of thyroid cancer K Sethi, S Sarkar, S Das, B Mohanty, M Mandal J Exp Ther Oncol 8 (4), 341-52, 2010 | 63 | 2010 |
| Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction R Dash, P Bhoopathi, SK Das, S Sarkar, L Emdad, S Dasgupta, D Sarkar, ... Cancer research 74 (2), 563-574, 2014 | 59 | 2014 |
| Enhanced delivery of mda‐7/IL‐24 using a serotype chimeric adenovirus (Ad. 5/3) in combination with the apogossypol derivative BI‐97C1 (Sabutoclax) improves therapeutic … B Azab, R Dash, SK Das, SK Bhutia, XN Shen, BA Quinn, S Sarkar, ... Journal of cellular physiology 227 (5), 2145-2153, 2012 | 54 | 2012 |
| The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance BC Jena, S Sarkar, L Rout, M Mandal Cancer Letters, 2021 | 47 | 2021 |
| Pancreatic cancer combination therapy using a BH3 mimetic and a synthetic tetracycline BA Quinn, R Dash, S Sarkar, B Azab, P Bhoopathi, SK Das, L Emdad, ... Cancer research 75 (11), 2305-2315, 2015 | 47 | 2015 |
| AEG-1 Promoter–Mediated Imaging of Prostate Cancer A Bhatnagar, Y Wang, RC Mease, M Gabrielson, P Sysa, I Minn, G Green, ... Cancer research 74 (20), 5772-5781, 2014 | 47 | 2014 |
| Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic R Dash, B Azab, XN Shen, UK Sokhi, S Sarkar, Z Su, XY Wang, ... Discovery medicine 11 (56), 46, 2011 | 46 | 2011 |
| Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma K Sethi, S Sarkar, S Das, S Rajput, A Mazumder, B Roy, S Patra, ... J Exp Ther Oncol 9 (3), 187-199, 2011 | 40 | 2011 |
| Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment S Sarkar, S Konar, PN Prasad, S Rajput, BNP Kumar, RR Rao, A Pathak, ... Langmuir 33 (31), 7649-7659, 2017 | 39 | 2017 |
| Cancer terminator viruses and approaches for enhancing therapeutic outcomes SK Das, S Sarkar, R Dash, P Dent, XY Wang, D Sarkar, PB Fisher Advances in cancer research 115, 1-38, 2012 | 38 | 2012 |
| Abrus agglutinin is a potent anti‐proliferative and anti‐angiogenic agent in human breast cancer SK Bhutia, B Behera, D Nandini Das, S Mukhopadhyay, N Sinha, ... International journal of cancer 139 (2), 457-466, 2016 | 37 | 2016 |
Mahitosh MandalProfessor, School of Medical Science and Technology,Indian Institute of Technology, Kharagpur, India在 smst.iitkgp.ac.in 的电子邮件经过验证
